Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 1,219,072 | 1,175,789 | 1,212,702 | 1,108,860 | 1,127,057 |
| Cost of Goods | 100,304 | 95,918 | 106,985 | 97,055 | 99,700 |
| Gross Profit | 1,118,768 | 1,079,871 | 1,105,717 | 1,011,805 | 1,027,357 |
| Operating Expenses | 763,887 | 886,654 | 710,822 | 708,171 | 644,680 |
| Operating Income | 355,185 | 194,135 | 395,880 | 303,689 | 383,377 |
| Other Income | -4,664 | -6,945 | 1,012 | -8,386 | 6,366 |
| Pre-tax Income | 350,521 | 187,190 | 396,892 | 295,303 | 389,743 |
| Income Tax | 78,769 | 75,011 | 102,243 | 75,310 | 83,747 |
| Net Income Continuous | 271,752 | 112,179 | 294,649 | 219,993 | 305,996 |
| Minority Interests | 31,474 | -141,936 | 1,211 | 2,551 | 359 |
| Net Income | $240,278 | $254,115 | $293,438 | $217,442 | $305,637 |
| EPS Basic Total Ops | 0.99 | 1.06 | 1.13 | 0.80 | 1.07 |
| EPS Basic Continuous Ops | 1.15 | 0.47 | 1.13 | 0.82 | 1.07 |
| EPS Diluted Total Ops | 0.97 | 1.05 | 1.12 | 0.80 | 1.07 |
| EPS Diluted Continuous Ops | 1.13 | 0.46 | 1.13 | 0.81 | 1.06 |
| EBITDA(a) | $450,840 | $284,263 | $483,331 | $386,199 | $476,577 |